Concepts (288)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Obesity, Morbid | 11 | 2025 | 233 | 3.130 |
Why?
|
| Laparoscopy | 11 | 2023 | 555 | 3.060 |
Why?
|
| Bariatric Surgery | 8 | 2025 | 155 | 1.940 |
Why?
|
| Pediatric Obesity | 7 | 2025 | 411 | 1.860 |
Why?
|
| Esophageal Atresia | 4 | 2024 | 52 | 1.310 |
Why?
|
| Moyamoya Disease | 3 | 2022 | 42 | 1.260 |
Why?
|
| Cerebral Revascularization | 3 | 2022 | 22 | 1.210 |
Why?
|
| Gastrectomy | 7 | 2025 | 107 | 1.180 |
Why?
|
| Communication Barriers | 2 | 2015 | 40 | 0.890 |
Why?
|
| Funnel Chest | 1 | 2024 | 33 | 0.810 |
Why?
|
| Omentum | 3 | 2022 | 44 | 0.750 |
Why?
|
| Patient Satisfaction | 2 | 2015 | 460 | 0.700 |
Why?
|
| Physician-Patient Relations | 2 | 2015 | 435 | 0.690 |
Why?
|
| Gastroschisis | 3 | 2017 | 58 | 0.670 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2024 | 201 | 0.650 |
Why?
|
| Endoscopy | 2 | 2024 | 284 | 0.650 |
Why?
|
| Sutures | 2 | 2017 | 65 | 0.610 |
Why?
|
| Surgical Flaps | 2 | 2022 | 187 | 0.570 |
Why?
|
| Respiratory System Abnormalities | 1 | 2018 | 45 | 0.560 |
Why?
|
| Pilomatrixoma | 1 | 2018 | 4 | 0.560 |
Why?
|
| Hair Diseases | 1 | 2018 | 14 | 0.550 |
Why?
|
| Pancreatic Neoplasms | 3 | 2009 | 732 | 0.550 |
Why?
|
| Facial Neoplasms | 1 | 2018 | 23 | 0.550 |
Why?
|
| Retrospective Studies | 22 | 2025 | 17667 | 0.540 |
Why?
|
| Hirschsprung Disease | 1 | 2017 | 36 | 0.540 |
Why?
|
| Hernia, Inguinal | 2 | 2015 | 42 | 0.540 |
Why?
|
| Ileostomy | 1 | 2017 | 31 | 0.530 |
Why?
|
| Dermoid Cyst | 1 | 2018 | 36 | 0.530 |
Why?
|
| Herniorrhaphy | 2 | 2015 | 75 | 0.530 |
Why?
|
| Sutureless Surgical Procedures | 1 | 2017 | 7 | 0.520 |
Why?
|
| Suture Techniques | 2 | 2015 | 180 | 0.510 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2017 | 87 | 0.510 |
Why?
|
| Adolescent | 23 | 2025 | 20994 | 0.510 |
Why?
|
| Tracheoesophageal Fistula | 3 | 2023 | 48 | 0.510 |
Why?
|
| Language | 2 | 2015 | 218 | 0.490 |
Why?
|
| Birth Weight | 2 | 2017 | 346 | 0.480 |
Why?
|
| Clinical Decision-Making | 1 | 2018 | 313 | 0.480 |
Why?
|
| Treatment Outcome | 20 | 2025 | 12997 | 0.480 |
Why?
|
| Ligation | 2 | 2015 | 137 | 0.470 |
Why?
|
| Intestine, Small | 1 | 2017 | 287 | 0.460 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2015 | 40 | 0.460 |
Why?
|
| Surgical Procedures, Operative | 2 | 2015 | 229 | 0.460 |
Why?
|
| Culturally Competent Care | 1 | 2015 | 50 | 0.450 |
Why?
|
| Lung Diseases | 1 | 2018 | 401 | 0.440 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2020 | 404 | 0.430 |
Why?
|
| Intellectual Disability | 1 | 2021 | 1082 | 0.410 |
Why?
|
| Humans | 49 | 2025 | 131781 | 0.400 |
Why?
|
| Venous Cutdown | 1 | 2013 | 2 | 0.400 |
Why?
|
| Choledochal Cyst | 1 | 2013 | 9 | 0.400 |
Why?
|
| Jugular Veins | 1 | 2013 | 74 | 0.390 |
Why?
|
| General Surgery | 1 | 2015 | 222 | 0.390 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 2013 | 104 | 0.370 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2018 | 2122 | 0.370 |
Why?
|
| Liver | 1 | 2020 | 1799 | 0.370 |
Why?
|
| Gastric Bypass | 2 | 2023 | 96 | 0.360 |
Why?
|
| Male | 30 | 2025 | 65290 | 0.360 |
Why?
|
| Lung | 2 | 2019 | 1566 | 0.350 |
Why?
|
| Child | 20 | 2025 | 26316 | 0.350 |
Why?
|
| Catheterization, Central Venous | 1 | 2013 | 140 | 0.350 |
Why?
|
| Splenectomy | 1 | 2011 | 63 | 0.350 |
Why?
|
| Weight Loss | 4 | 2025 | 529 | 0.330 |
Why?
|
| Body Mass Index | 4 | 2023 | 1695 | 0.320 |
Why?
|
| Skin Neoplasms | 1 | 2018 | 904 | 0.320 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2018 | 3917 | 0.320 |
Why?
|
| Female | 31 | 2025 | 71221 | 0.320 |
Why?
|
| Infant, Newborn | 8 | 2019 | 8597 | 0.310 |
Why?
|
| Infant | 10 | 2025 | 13324 | 0.300 |
Why?
|
| Pediatrics | 2 | 2015 | 1232 | 0.290 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2009 | 62 | 0.290 |
Why?
|
| Neuroendocrine Tumors | 1 | 2009 | 59 | 0.280 |
Why?
|
| Splenic Vein | 1 | 2008 | 11 | 0.280 |
Why?
|
| Splenic Artery | 1 | 2008 | 24 | 0.280 |
Why?
|
| Physicians | 1 | 2014 | 634 | 0.280 |
Why?
|
| Short Bowel Syndrome | 1 | 2008 | 63 | 0.270 |
Why?
|
| Pancreatectomy | 1 | 2008 | 146 | 0.260 |
Why?
|
| Spleen | 1 | 2008 | 256 | 0.260 |
Why?
|
| Laparotomy | 1 | 2008 | 144 | 0.260 |
Why?
|
| Ultrasonography | 3 | 2017 | 975 | 0.250 |
Why?
|
| Parenteral Nutrition | 1 | 2008 | 216 | 0.250 |
Why?
|
| Neuroblastoma | 2 | 2022 | 557 | 0.240 |
Why?
|
| Prospective Studies | 7 | 2025 | 6509 | 0.230 |
Why?
|
| Child, Preschool | 12 | 2022 | 15057 | 0.230 |
Why?
|
| Follow-Up Studies | 7 | 2023 | 5297 | 0.230 |
Why?
|
| Appendicitis | 2 | 2017 | 132 | 0.230 |
Why?
|
| Basal Metabolism | 1 | 2025 | 93 | 0.220 |
Why?
|
| Portoenterostomy, Hepatic | 1 | 2025 | 61 | 0.220 |
Why?
|
| Intestines | 1 | 2008 | 592 | 0.210 |
Why?
|
| Magnets | 1 | 2024 | 19 | 0.210 |
Why?
|
| Fluoroscopy | 1 | 2024 | 100 | 0.200 |
Why?
|
| Intestinal Atresia | 2 | 2017 | 21 | 0.200 |
Why?
|
| Acetates | 1 | 2023 | 83 | 0.200 |
Why?
|
| Glucocorticoids | 1 | 2025 | 350 | 0.200 |
Why?
|
| Postoperative Complications | 6 | 2023 | 3134 | 0.190 |
Why?
|
| 3-Iodobenzylguanidine | 1 | 2022 | 12 | 0.190 |
Why?
|
| Esophagoplasty | 1 | 2022 | 13 | 0.190 |
Why?
|
| Leiomyomatosis | 1 | 2022 | 7 | 0.190 |
Why?
|
| Basal Cell Nevus Syndrome | 1 | 2022 | 15 | 0.180 |
Why?
|
| Biliary Atresia | 1 | 2025 | 220 | 0.180 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2023 | 1413 | 0.180 |
Why?
|
| Rectal Fistula | 1 | 2021 | 4 | 0.180 |
Why?
|
| Anus, Imperforate | 1 | 2021 | 19 | 0.180 |
Why?
|
| Urethral Diseases | 1 | 2021 | 17 | 0.170 |
Why?
|
| Urinary Fistula | 1 | 2021 | 19 | 0.170 |
Why?
|
| Diverticulum | 1 | 2021 | 26 | 0.170 |
Why?
|
| Ehlers-Danlos Syndrome | 1 | 2021 | 51 | 0.160 |
Why?
|
| Energy Metabolism | 1 | 2025 | 785 | 0.160 |
Why?
|
| Intraoperative Period | 1 | 2020 | 65 | 0.160 |
Why?
|
| Cystic Adenomatoid Malformation of Lung, Congenital | 1 | 2019 | 19 | 0.160 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2020 | 83 | 0.150 |
Why?
|
| Intraoperative Care | 1 | 2020 | 122 | 0.150 |
Why?
|
| Telomerase | 1 | 2020 | 157 | 0.150 |
Why?
|
| Cerebellar Neoplasms | 1 | 2022 | 320 | 0.140 |
Why?
|
| Preoperative Period | 1 | 2018 | 92 | 0.140 |
Why?
|
| Liver Neoplasms | 1 | 2009 | 1393 | 0.140 |
Why?
|
| Eyebrows | 1 | 2018 | 8 | 0.140 |
Why?
|
| Medulloblastoma | 1 | 2022 | 384 | 0.140 |
Why?
|
| Forehead | 1 | 2018 | 10 | 0.140 |
Why?
|
| Epidermal Cyst | 1 | 2018 | 17 | 0.140 |
Why?
|
| Dyslipidemias | 1 | 2021 | 247 | 0.140 |
Why?
|
| Pilot Projects | 2 | 2021 | 1457 | 0.140 |
Why?
|
| Patient Care Planning | 1 | 2018 | 123 | 0.140 |
Why?
|
| Young Adult | 7 | 2021 | 10102 | 0.130 |
Why?
|
| Pylorus | 1 | 2017 | 20 | 0.130 |
Why?
|
| Pneumonectomy | 1 | 2018 | 151 | 0.130 |
Why?
|
| Prenatal Care | 1 | 2019 | 346 | 0.130 |
Why?
|
| Fundoplication | 1 | 2017 | 70 | 0.130 |
Why?
|
| Cicatrix | 1 | 2018 | 127 | 0.130 |
Why?
|
| Sensitivity and Specificity | 2 | 2018 | 2148 | 0.120 |
Why?
|
| Prevalence | 2 | 2021 | 2695 | 0.120 |
Why?
|
| Biopsy | 1 | 2020 | 1252 | 0.120 |
Why?
|
| Diaphragm | 1 | 2017 | 102 | 0.120 |
Why?
|
| Peutz-Jeghers Syndrome | 1 | 2016 | 28 | 0.120 |
Why?
|
| Patient Selection | 1 | 2020 | 726 | 0.120 |
Why?
|
| Time Factors | 3 | 2021 | 6279 | 0.120 |
Why?
|
| Gestational Age | 2 | 2017 | 1235 | 0.120 |
Why?
|
| Gastroscopy | 1 | 2016 | 98 | 0.120 |
Why?
|
| Testicular Hydrocele | 1 | 2015 | 2 | 0.120 |
Why?
|
| Dissection | 1 | 2016 | 59 | 0.120 |
Why?
|
| Telemedicine | 1 | 2022 | 524 | 0.110 |
Why?
|
| Cell Cycle Proteins | 1 | 2020 | 703 | 0.110 |
Why?
|
| California | 1 | 2015 | 128 | 0.110 |
Why?
|
| Hamartoma | 1 | 2016 | 52 | 0.110 |
Why?
|
| Gastric Fistula | 1 | 2014 | 3 | 0.110 |
Why?
|
| Angiography | 1 | 2015 | 188 | 0.110 |
Why?
|
| Home Childbirth | 1 | 2015 | 39 | 0.110 |
Why?
|
| Cohort Studies | 3 | 2020 | 5122 | 0.110 |
Why?
|
| Maternal Age | 1 | 2015 | 136 | 0.110 |
Why?
|
| Cutaneous Fistula | 1 | 2014 | 21 | 0.110 |
Why?
|
| Hospitals, Urban | 1 | 2015 | 99 | 0.110 |
Why?
|
| Hospitals, Teaching | 1 | 2015 | 109 | 0.110 |
Why?
|
| Health Care Surveys | 1 | 2015 | 282 | 0.110 |
Why?
|
| Hematoma | 1 | 2015 | 90 | 0.110 |
Why?
|
| Quality Improvement | 2 | 2023 | 707 | 0.110 |
Why?
|
| Epigenesis, Genetic | 1 | 2020 | 766 | 0.110 |
Why?
|
| Metabolic Syndrome | 1 | 2018 | 363 | 0.110 |
Why?
|
| United States | 4 | 2021 | 11815 | 0.110 |
Why?
|
| Gastrostomy | 1 | 2014 | 88 | 0.110 |
Why?
|
| Infant Mortality | 1 | 2015 | 182 | 0.100 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 2299 | 0.100 |
Why?
|
| Prenatal Diagnosis | 1 | 2018 | 653 | 0.100 |
Why?
|
| Length of Stay | 3 | 2025 | 1400 | 0.100 |
Why?
|
| Specialties, Surgical | 1 | 2014 | 90 | 0.100 |
Why?
|
| Societies, Medical | 1 | 2018 | 796 | 0.100 |
Why?
|
| Immunosuppressive Agents | 1 | 2017 | 667 | 0.100 |
Why?
|
| Adult | 9 | 2021 | 31710 | 0.100 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2014 | 233 | 0.100 |
Why?
|
| Aged, 80 and over | 3 | 2009 | 6916 | 0.100 |
Why?
|
| Developing Countries | 1 | 2015 | 305 | 0.100 |
Why?
|
| Gastric Mucosa | 1 | 2016 | 491 | 0.090 |
Why?
|
| Thoracic Neoplasms | 1 | 2012 | 37 | 0.090 |
Why?
|
| Anastomosis, Surgical | 2 | 2023 | 175 | 0.090 |
Why?
|
| Hypertension | 1 | 2021 | 1360 | 0.090 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 2017 | 432 | 0.090 |
Why?
|
| Surgical Mesh | 1 | 2012 | 65 | 0.090 |
Why?
|
| Thoracic Wall | 1 | 2012 | 41 | 0.090 |
Why?
|
| Middle Aged | 5 | 2021 | 28897 | 0.090 |
Why?
|
| Umbilicus | 1 | 2011 | 14 | 0.090 |
Why?
|
| Obesity | 2 | 2021 | 2390 | 0.090 |
Why?
|
| Wound Healing | 1 | 2015 | 476 | 0.090 |
Why?
|
| Biocompatible Materials | 1 | 2012 | 122 | 0.090 |
Why?
|
| Recurrence | 1 | 2015 | 1483 | 0.090 |
Why?
|
| Neurosurgical Procedures | 1 | 2014 | 317 | 0.080 |
Why?
|
| Reoperation | 3 | 2025 | 844 | 0.080 |
Why?
|
| Collagen | 1 | 2012 | 289 | 0.080 |
Why?
|
| Transcription Factors | 1 | 2020 | 2438 | 0.080 |
Why?
|
| Antineoplastic Agents | 1 | 2020 | 1811 | 0.080 |
Why?
|
| Infant, Premature | 1 | 2015 | 857 | 0.080 |
Why?
|
| Pregnancy | 2 | 2019 | 7575 | 0.070 |
Why?
|
| Enterostomy | 1 | 2008 | 6 | 0.070 |
Why?
|
| Nebraska | 1 | 2008 | 2 | 0.070 |
Why?
|
| Intestinal Volvulus | 1 | 2008 | 41 | 0.070 |
Why?
|
| Incidental Findings | 1 | 2008 | 125 | 0.060 |
Why?
|
| Age of Onset | 1 | 2008 | 631 | 0.060 |
Why?
|
| Diphosphonates | 1 | 2006 | 41 | 0.060 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2006 | 58 | 0.060 |
Why?
|
| Bone Density Conservation Agents | 1 | 2006 | 58 | 0.060 |
Why?
|
| Aged | 3 | 2009 | 21263 | 0.060 |
Why?
|
| Carotid Stenosis | 1 | 2006 | 107 | 0.060 |
Why?
|
| Cholangitis | 1 | 2025 | 40 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2025 | 1626 | 0.060 |
Why?
|
| Calorimetry, Indirect | 1 | 2025 | 65 | 0.060 |
Why?
|
| Cerebral Palsy | 1 | 2006 | 86 | 0.060 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2008 | 255 | 0.060 |
Why?
|
| Absorptiometry, Photon | 1 | 2025 | 199 | 0.050 |
Why?
|
| Adrenal Gland Diseases | 1 | 2004 | 16 | 0.050 |
Why?
|
| Wounds and Injuries | 1 | 2008 | 395 | 0.050 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2025 | 393 | 0.050 |
Why?
|
| Cysts | 1 | 2004 | 93 | 0.050 |
Why?
|
| Compassionate Use Trials | 1 | 2023 | 17 | 0.050 |
Why?
|
| Emergency Service, Hospital | 3 | 2017 | 1217 | 0.050 |
Why?
|
| Accreditation | 1 | 2023 | 89 | 0.050 |
Why?
|
| Radionuclide Imaging | 1 | 2022 | 120 | 0.050 |
Why?
|
| Iodine Radioisotopes | 1 | 2022 | 74 | 0.050 |
Why?
|
| Body Composition | 1 | 2025 | 550 | 0.050 |
Why?
|
| Patient Readmission | 1 | 2025 | 423 | 0.040 |
Why?
|
| Transferrin | 1 | 2021 | 45 | 0.040 |
Why?
|
| Nutrition Disorders | 1 | 2021 | 27 | 0.040 |
Why?
|
| Hemorrhage | 1 | 2004 | 498 | 0.040 |
Why?
|
| Stents | 1 | 2006 | 778 | 0.040 |
Why?
|
| Incidence | 1 | 2008 | 3349 | 0.040 |
Why?
|
| Remission Induction | 1 | 2021 | 309 | 0.040 |
Why?
|
| Indolizines | 1 | 2020 | 9 | 0.040 |
Why?
|
| Heterocyclic Compounds, 2-Ring | 1 | 2020 | 3 | 0.040 |
Why?
|
| Cyclic N-Oxides | 1 | 2020 | 18 | 0.040 |
Why?
|
| Pyridinium Compounds | 1 | 2020 | 28 | 0.040 |
Why?
|
| Vitamin D Deficiency | 1 | 2021 | 85 | 0.040 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 2020 | 50 | 0.040 |
Why?
|
| Pyridazines | 1 | 2020 | 53 | 0.040 |
Why?
|
| Risk Factors | 2 | 2015 | 10965 | 0.040 |
Why?
|
| Stroke | 1 | 2006 | 1049 | 0.030 |
Why?
|
| Inpatients | 1 | 2022 | 544 | 0.030 |
Why?
|
| Bone Marrow | 1 | 2020 | 314 | 0.030 |
Why?
|
| Piperazines | 1 | 2020 | 272 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 2022 | 781 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2020 | 832 | 0.030 |
Why?
|
| Pyrazoles | 1 | 2020 | 359 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2020 | 999 | 0.030 |
Why?
|
| Chromatin | 1 | 2020 | 491 | 0.030 |
Why?
|
| Liver Transplantation | 1 | 2025 | 1133 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2020 | 1219 | 0.030 |
Why?
|
| Histones | 1 | 2020 | 533 | 0.030 |
Why?
|
| Comorbidity | 1 | 2021 | 1600 | 0.030 |
Why?
|
| Zimbabwe | 1 | 2015 | 7 | 0.030 |
Why?
|
| Mozambique | 1 | 2015 | 23 | 0.030 |
Why?
|
| Surgery Department, Hospital | 1 | 2015 | 21 | 0.030 |
Why?
|
| Pandemics | 1 | 2022 | 1165 | 0.030 |
Why?
|
| Age Factors | 1 | 2021 | 2872 | 0.030 |
Why?
|
| Abdominal Pain | 1 | 2016 | 316 | 0.030 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2019 | 1005 | 0.030 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2014 | 101 | 0.030 |
Why?
|
| Operative Time | 1 | 2014 | 205 | 0.030 |
Why?
|
| Cerebral Angiography | 1 | 2014 | 106 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2015 | 773 | 0.030 |
Why?
|
| Overweight | 1 | 2016 | 377 | 0.030 |
Why?
|
| Stomach | 1 | 2016 | 274 | 0.020 |
Why?
|
| Neoplasms | 1 | 2008 | 2963 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 1406 | 0.020 |
Why?
|
| Equipment Design | 1 | 2014 | 555 | 0.020 |
Why?
|
| Blood Loss, Surgical | 1 | 2014 | 169 | 0.020 |
Why?
|
| Transcriptome | 1 | 2020 | 1150 | 0.020 |
Why?
|
| Neuroectodermal Tumors, Primitive, Peripheral | 1 | 2012 | 14 | 0.020 |
Why?
|
| Sarcoma, Synovial | 1 | 2012 | 22 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2020 | 2004 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2020 | 3694 | 0.020 |
Why?
|
| Logistic Models | 1 | 2016 | 1838 | 0.020 |
Why?
|
| Brain Ischemia | 1 | 2014 | 261 | 0.020 |
Why?
|
| Sarcoma, Ewing | 1 | 2012 | 117 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 1304 | 0.020 |
Why?
|
| Patient Discharge | 1 | 2015 | 507 | 0.020 |
Why?
|
| Premature Birth | 1 | 2015 | 414 | 0.020 |
Why?
|
| Quality of Life | 1 | 2021 | 2115 | 0.020 |
Why?
|
| Scoliosis | 1 | 2012 | 145 | 0.020 |
Why?
|
| Cerebrovascular Circulation | 1 | 2014 | 487 | 0.020 |
Why?
|
| Secondary Prevention | 1 | 2011 | 220 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2018 | 3696 | 0.020 |
Why?
|
| Prognosis | 1 | 2018 | 4953 | 0.020 |
Why?
|
| Bone Neoplasms | 1 | 2012 | 441 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2020 | 4682 | 0.020 |
Why?
|
| Mobility Limitation | 1 | 2006 | 35 | 0.020 |
Why?
|
| Angioplasty, Balloon | 1 | 2006 | 128 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2006 | 549 | 0.010 |
Why?
|
| Ultrasonography, Interventional | 1 | 2006 | 204 | 0.010 |
Why?
|
| Fractures, Bone | 1 | 2006 | 207 | 0.010 |
Why?
|
| Bone Density | 1 | 2006 | 362 | 0.010 |
Why?
|
| Mice | 1 | 2020 | 18479 | 0.010 |
Why?
|
| Brain | 1 | 2014 | 3236 | 0.010 |
Why?
|
| Animals | 1 | 2020 | 34402 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2006 | 3094 | 0.010 |
Why?
|